As part of programs in diabetes, neurodegenerative diseases and several other diseases, drug companies are increasingly interested in developing compounds that can improve mitochondrial function or increase total mitochondria.

Most of these efforts are focused on reducing oxidative stress, enhancing electron transport, or up-regulating mitochondrial biogenesis. MitoSciences has the best tools and services on the market for measuring and differentiating all of these effects.

The same assays that are used in multiplex arrays to discover useful compounds can also be used on platforms suitable for minimally-invasive sample types in animal studies and clinical trials.